PRO: Patients With Metastatic/Recurrent Cervical Cancer Should Be Treated With Cisplatin Plus Paclitaxel
Clinical Ovarian Cancer
doi 10.1016/j.cloc.2012.02.014
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2011
Authors
Publisher
Elsevier BV